You are here: Industry Insights > HIV

News List

Rates of HIV rise amongst older population pharmafile
September 29, 2017
It is rare to hear bad news in the fight against the spread of HIV, with the global campaign against the virus leading to better support, awareness and access to antiretroviral medicines.
HIV epidemic control to be achieved by 2020 europeanpharmaceuticalreview
September 20, 2017
Data from the PEPFAR has shown that the HIV epidemic is coming under control in Lesotho.
Scientists discovers cancer drug that can reactivate HIV europeanpharmaceuticalreview
August 28, 2017
A team of scientists have recently discovered how a new drug called JQ1 can reactivate latent HIV…
HIV home tests seized from market over potential risk pharmafile
August 25, 2017
The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not to contain a valid CE mark. The CE mark indicates that...
Mylan launches three generic anti-retroviral treatments for HIV patients in Canada pharmaceutical-technology
August 15, 2017
US-based Mylan's Canadian subsidiary Mylan Pharmaceuticals has launched three generic anti-retroviral (ARV) medicines for the treatment of HIV for certain patients in Canada.The company has received final approval from Health Canada for the three products
Mylan Launches Three Generic Antiretroviral Medicines in Canada americanpharmaceuticalreview
August 11, 2017
Mylan Pharmaceuticals announced the launch in Canada of three generic products indicated in the treatment of HIV for certain patients. One of the products is Mylan-Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg, a generic alternative to Truvada
Bristol-Myers Squibb nixes 58 marketing jobs as HIV medications near patent cliff fiercepharma
August 10, 2017
Six of the workers set to lose their posts in Bristol-Myers HIV unit live in New Jersey, while 52 work remotely.
NHS England launches trial to assess PrEP pharmatimes
August 08, 2017
NHS England has kicked off what it claims to be the world’s largest single trial assessing the full impact of a scheme that gives patients at high risk of contracting HIV drugs to prevent infection.
HIV-preventing drug to be trialed across England pharmafile
August 08, 2017
NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the beginning of a three-year, £10 million trial.
New injectable antiretroviral treatment for HIV patients europeanpharmaceuticalreview
August 04, 2017
A phase II clinical trial has paved the way to the implantation of all-injectable antiretroviral therapies with a lower frequency of administration…

Previous page 1 2 3 4 5 6 7 8 9 10 ... 24 25 Next page